Disialyllacto-N-tetraose

CAS : 61278-38-4

Ref. 3D-OD00173

Informations sur le produit

• Nom: Disialyllacto-N-tetraose
• Synonymes: a-NeuNAc-(2-3)-b-Gal-(1-3)-[a-NeuNAc-(2-6)]-b-GlcNAc-(1-3)-b-Gal-(1-4)-GlcDSLNT, <span class="text-smallcaps">D</smallcap>-Glucose, O-(N-acetyl-α-neuraminosyl)-(2→6)-O-[O-(N-acetyl-α-neuraminosyl)-(2→3)-β-<smallcap>D</smallcap>-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-<smallcap>D</smallcap>-glucopyranosyl-(1→3)-O-β-<smallcap>D</span>-galactopyranosyl-(1→4)-, Di-N-Acetylneuraminosyllacto-N-tetraose, Disialyllacto-N-tetraose, Disodium Salt, Human Milk, O-(N-Acetyl-α-neuraminosyl)-(2→6)-O-[O-(N-acetyl-α-neuraminosyl)-(2→3)-β-<span class="text-smallcaps">D</smallcap>-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-<smallcap>D</smallcap>-glucopyranosyl-(1→3)-O-β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)-<smallcap>D</span>-glucose
• CAS: 61278-38-4

Description

Disialyllacto-N-tetraose is a medicinal compound that has shown promising anticancer properties. It is an analog of a human urinary glycoprotein and has been found to induce apoptosis in cancer cells. Disialyllacto-N-tetraose acts as a tumor inhibitor by blocking the activity of certain protein kinases, which are enzymes that play a role in cell growth and division. This compound has been studied extensively in Chinese medicine and has shown potential as an effective anticancer agent. Its unique structure and mechanism of action make it a promising candidate for further research into cancer treatment.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,290.16 g/mol
• Formule: C₄₈H₇₉N₃O₃₇
• Degré de pureté: Min. 85%